Elicera Therapeutics

Margareth Jorvid, regulatory expert and board member of Elicera Therapeutics, will participate in a networking session to present the company's scientific poster titled " iTANK PLATFORM DERIVED ELC-301 FOR LYMPHOMA: COMPLETE REMISSION DATA REPORTED FOR FOUR OF SIX PATIENTS IN FIRST TWO COHORTS OF CARMA-01 STUDY".

ISCT brings together leading researchers, clinicians, and industry experts in cell and gene therapy from around the world. The primary goal of the conference is to facilitate the exchange of new scientific advancements, technological innovations, and clinical insights in the rapidly evolving field of cell and gene therapy.

For more information: https://www.isctglobal.org/annual-meeting/home